{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:04:26Z","timestamp":1785074666288,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejon.2026.103264","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:32:11Z","timestamp":1783035131000},"page":"103264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["When the body becomes unfamiliar: symptom severity and experiences of chemotherapy-induced peripheral neuropathy in a sequential explanatory mixed-methods study"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-5598","authenticated-orcid":false,"given":"Yasemin","family":"Eskig\u00fclek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Kav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"\u00c7evik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclay","family":"Turgay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"\u00d6zen\u00e7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedriye","family":"Erten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2026.103264_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2025.102921","article-title":"Living with chemotherapy-induced peripheral neuropathy: a qualitative meta-synthesis of patient experiences","volume":"77","author":"Amarelo","year":"2025","journal-title":"Eur. J. Oncol. Nurs. : the official journal of European Oncology Nursing Society"},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jns.12616","article-title":"Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: a file-based observational study","volume":"29","author":"Argyriou","year":"2024","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"3","key":"10.1016\/j.ejon.2026.103264_bib3","first-page":"411","article-title":"What you see May not be what you get: a brief, nontechnical introduction to overfitting in regression-type models","volume":"66","author":"Babyak","year":"2004","journal-title":"Biopsychosocial Science and Medicine"},{"issue":"2","key":"10.1016\/j.ejon.2026.103264_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual. Res. Psychol."},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/26895269.2022.2129597","article-title":"Toward good practice in thematic analysis: avoiding common problems and be(com)ing a knowing researcher","volume":"24","author":"Braun","year":"2022","journal-title":"Int. J. Transgender Health"},{"issue":"3","key":"10.1016\/j.ejon.2026.103264_bib6","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ejon.2026.103264_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol. Ther."},{"issue":"6","key":"10.1016\/j.ejon.2026.103264_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ijgc-00009577-200311000-00003","article-title":"Psychometric evaluation of the Functional Assessment of Cancer Therapy\/Gynecologic Oncology Group-Neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy","volume":"13","author":"Calhoun","year":"2003","journal-title":"Int. J. Gynecol. Cancer : official journal of the International Gynecological Cancer Society"},{"key":"10.1016\/j.ejon.2026.103264_bib9","doi-asserted-by":"crossref","unstructured":"Cavaletti, G., Alberti, P., Argyriou, A.A., Lustberg, M., Staff, N.P., Tamburin, S., Toxic Neuropathy Consortium of the Peripheral Nerve society, 2019. Chemotherapy-induced peripheral neurotoxicity: a multifaceted, still unsolved issue. J. Peripher. Nerv. Syst. 24 Suppl. 2, S6\u2013S12. https:\/\/doi.org\/10.1111\/jns.12337.","DOI":"10.1111\/jns.12337"},{"issue":"Suppl. 1","key":"10.1016\/j.ejon.2026.103264_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","article-title":"Chemotherapy-induced peripheral neuropathy: where are we now?","volume":"160","author":"Colvin","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.ejon.2026.103264_bib11","series-title":"Designing and Conducting Mixed Methods Research","author":"Creswell","year":"2018"},{"issue":"4","key":"10.1016\/j.ejon.2026.103264_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0897-1897(05)80008-4","article-title":"Instrument review: getting the most from a panel of experts","volume":"5","author":"Davis","year":"1992","journal-title":"Appl. Nurs. Res."},{"key":"10.1016\/j.ejon.2026.103264_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112671","article-title":"Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update","volume":"147","author":"Desforges","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"6 Pt 2","key":"10.1016\/j.ejon.2026.103264_bib14","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/1475-6773.12117","article-title":"Achieving integration in mixed methods designs-principles and practices","volume":"48","author":"Fetters","year":"2013","journal-title":"Health Serv. Res."},{"issue":"3","key":"10.1016\/j.ejon.2026.103264_bib15","doi-asserted-by":"crossref","first-page":"E111","DOI":"10.1188\/17.ONF.E111-E123","article-title":"Chemotherapy-induced peripheral neuropathy assessment tools: a systematic review","volume":"44","author":"Haryani","year":"2017","journal-title":"Oncol. Nurs. Forum"},{"issue":"4","key":"10.1016\/j.ejon.2026.103264_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1049732316665344","article-title":"Code saturation versus meaning saturation: how many interviews are enough?","volume":"27","author":"Hennink","year":"2017","journal-title":"Qual. Health Res."},{"key":"10.1016\/j.ejon.2026.103264_bib17","series-title":"Handbook of Univariate and Multivariate Data Analysis with IBM SPSS","author":"Ho","year":"2013"},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/17482631.2022.2049437","article-title":"A new self-understanding as chemo sufferer - a phenomenological study of everyday life with chemotherapy induced neuropathy among survivors after colorectal cancer","volume":"17","author":"Jensen","year":"2022","journal-title":"Int. J. Qual. Stud. Health Well-Being"},{"key":"10.1016\/j.ejon.2026.103264_bib19","article-title":"Mixed-methods Study of the effect of chemotherapy-induced peripheral Neuropathy SymptomPermanence on patient's willingness to alter neurotoxic chemotherapy treatment","author":"Jun","year":"2025","journal-title":"Research square"},{"issue":"3","key":"10.1016\/j.ejon.2026.103264_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NAN.0000000000000368","article-title":"Chemotherapy-induced peripheral neuropathy: nursing implications","volume":"43","author":"Kanzawa-Lee","year":"2020","journal-title":"J. Infusion Nurs."},{"issue":"5","key":"10.1016\/j.ejon.2026.103264_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2023.151499","article-title":"Real-life experiences of chemotherapy-induced peripheral neuropathy in patients with cancer: a qualitative meta-synthesis study","volume":"39","author":"Kim","year":"2023","journal-title":"Semin. Oncol. Nurs."},{"issue":"3","key":"10.1016\/j.ejon.2026.103264_bib23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s13187-022-02206-3","article-title":"Exploring patients' understanding of chemotherapy-induced peripheral neuropathy","volume":"38","author":"Knoerl","year":"2023","journal-title":"J. Cancer Educ."},{"key":"10.1016\/j.ejon.2026.103264_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejon.2017.10.001","article-title":"The psychometric properties of the Turkish version of the chemotherapy-induced peripheral neuropathy assessment tool (CIPNAT)","volume":"31","author":"Kutlut\u00fcrkan","year":"2017","journal-title":"Eur. J. Oncol. Nurs."},{"issue":"28","key":"10.1016\/j.ejon.2026.103264_bib25","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.ejon.2026.103264_bib26","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual. Health Res."},{"issue":"6","key":"10.1016\/j.ejon.2026.103264_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1312","article-title":"Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy","volume":"9","author":"Molassiotis","year":"2019","journal-title":"Brain Behav"},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12885-019-5302-4","article-title":"Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy","volume":"19","author":"Molassiotis","year":"2019","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ejon.2026.103264_bib29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations","volume":"89","author":"O'Brien","year":"2014","journal-title":"Acad. Med."},{"issue":"2","key":"10.1016\/j.ejon.2026.103264_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1258\/jhsrp.2007.007074","article-title":"The quality of mixed methods studies in health services research","volume":"13","author":"O'Cathain","year":"2008","journal-title":"J. Health Serv. Res. Policy"},{"issue":"8","key":"10.1016\/j.ejon.2026.103264_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","article-title":"The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20","volume":"41","author":"Postma","year":"2005","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-46039-2","article-title":"Touch and manual action in chemotherapy-induced peripheral neuropathy: a mixed-methods study","volume":"16","author":"Roberts","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejon.2026.103264_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40780-017-0089-4","article-title":"Objective evaluation of chemotherapy-induced peripheral neuropathy using quantitative pain measurement system (Pain vision\u00ae), a pilot study","volume":"3","author":"Sato","year":"2017","journal-title":"J. Pharm. Health Care Sci."},{"issue":"6","key":"10.1016\/j.ejon.2026.103264_bib34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/10547738221085613","article-title":"Severity, risk factors and quality of life of patients associated with chemotherapy-induced peripheral neuropathy","volume":"31","author":"Srivastava","year":"2022","journal-title":"Clin. Nurs. Res."},{"key":"10.1016\/j.ejon.2026.103264_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s11764-021-00997-w","article-title":"A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms","volume":"17","author":"Tanay","year":"2023","journal-title":"J. Cancer Surviv."},{"issue":"5","key":"10.1016\/j.ejon.2026.103264_bib36","article-title":"The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis","volume":"26","author":"Tanay","year":"2017","journal-title":"Eur. J. Cancer Care"},{"issue":"1","key":"10.1016\/j.ejon.2026.103264_bib37","article-title":"Clinician and patient experiences when providing and receiving information and support for managing chemotherapy-induced peripheral neuropathy: a qualitative multiple methods study","volume":"31","author":"Tanay","year":"2022","journal-title":"Eur. J. Cancer Care"},{"issue":"3","key":"10.1016\/j.ejon.2026.103264_bib39","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","article-title":"Patient perceptions associated with chemotherapy-induced peripheral neuropathy","volume":"14","author":"Tofthagen","year":"2010","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"4","key":"10.1016\/j.ejon.2026.103264_bib40","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1097\/NCC.0b013e31820251de","article-title":"Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool","volume":"34","author":"Tofthagen","year":"2011","journal-title":"Cancer Nurs."},{"issue":"5","key":"10.1016\/j.ejon.2026.103264_bib41","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s11764-023-01402-4","article-title":"Experiences of cancer survivors with chemotherapy-induced peripheral neuropathy in the Netherlands: symptoms, daily limitations, involvement of healthcare professionals, and social support","volume":"18","author":"van de Graaf","year":"2024","journal-title":"J. Cancer Surviv."},{"issue":"8","key":"10.1016\/j.ejon.2026.103264_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"20","key":"10.1016\/j.ejon.2026.103264_bib43","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejon.2026.103264_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2026.1672180","article-title":"Incidence and influencing factors of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis","volume":"17","author":"Yan","year":"2026","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.ejon.2026.103264_bib45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zaj\u0105czkowska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejon.2026.103264_bib46","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.21037\/tcr-2025-591","article-title":"Factors affecting chemotherapy-induced peripheral neuropathy in patients with breast cancer: a cross-sectional study in China","volume":"14","author":"Zhang","year":"2025","journal-title":"Transl. Cancer Res."}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388926001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388926001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:54:27Z","timestamp":1785074067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388926001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S1462388926001699"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2026.103264","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When the body becomes unfamiliar: symptom severity and experiences of chemotherapy-induced peripheral neuropathy in a sequential explanatory mixed-methods study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2026.103264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103264"}}